Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global Digital Therapeutics Market Outlook

The global digital therapeutics market size was valued at USD 4.5 billion in 2024, driven by the growing prevalence of telehealth services across the globe. The market is expected to grow at a CAGR of 31.6% during the forecast period of 2025-2034, with the values likely to rise from USD 5.92 billion in 2025 to USD 53.2 billion by 2034.

Global Digital Therapeutics Market Overview

Digital therapeutics are therapeutic interventions that help in patient treatment, management, and disease prevention with the help of evidence based and clinically evaluated software. It delivers therapies using smartphones, tablets and similar technologies and offers clinically safe and effective therapies to patients. The market is impacted by the increasing prevalence of chronic diseases and the rising convergence of digital technologies, artificial intelligence, and machine learning capabilities along with the advent of sensor capabilities.

Global Digital Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increased Application in Clinical Trials to Aid the Market Growth

In December 2023, ObvioHealth  announced the launch of their new API (application programming interface), tailored particularly for digital therapeutic clinical trials. The new electronic clinical outcome assessment (eCOA) solution integrates enhanced study design technology with scientific and clinical services. It enables rapid publishing of the assessment on the mobile apps to offer more robust results for trial sponsors. It also evaluates patient engagement tactics and offers personalized assistance to patients, ensuring their safety as well.

Rising Collaborations Between Pharmaceutical Giants and Prescription Digital Therapeutics Makers

With the vision to integrate technology related components in their product range and enter the digital health space, several pharmaceutical companies have started partnering with PDTs. In September 2023, Bayer AG entered a partnership with Mahana Therapeutics  to commercialize irritable bowel syndrome (IBS) related digital therapies. Mahana IBS, the company’s lead product uses cognitive behavioral therapy (CBT) to impact gut-brain communication. The agenda of such collaborations is primarily focused on connecting consumers with digital health tools. Hence, it is expected to impact the digital therapeutics market growth substantially.

Innovative Product Launches for Enhanced Services to Significantly Benefit the Market

To improve the quality of patient care in the upcoming ages, healthcare companies have realized that digital therapeutics is poised to play an active role in healthcare management. The shift has been significant, especially post COVID-19. Consequently, there have been comprehensive upgrades and new product launches to meet the rising digital therapeutics market demand. In November 2023, the Digital Therapeutics Alliance  (DTA) launched a Policymaker & Payor DTx Evaluation Toolkit, which includes components like foundation setting materials, DTx assessment guides and implementation resources. It featured market access pathways, prescription vs non-prescription statuses, along with clinical and economic impact of products along with its security, privacy, usability, and evidence requirements.

Software Segment is Expected to Lead the Digital Therapeutics Market Share

Based on components, the market is broadly divided into software and devices. Out of the two, the software segment is projected to dominate the market, which can be attributed to rising prevalence of applications that improve the user interface and convenience for both patients and healthcare providers. There has been continuous development in the existing models to bring relevant changes. One such example is Freespira’s Bluetooth  wireless technology enabled devices which come with sensor samples, measuring exhaled carbon dioxide and respiration rate, and directly transmitting the data to Freespira’s application.

Growing Emphasis on Preventive Healthcare in the Geriatric Population

The rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics are all driving the digital therapeutics market growth. Chronic diseases' high incidence rate is a serious problem for healthcare systems all over the world. Patients with chronic diseases provide a considerable barrier in terms of therapy, since psychosomatic or biopsychic variables frequently affect these patients. Many chronic diseases and conditions progress over time, and their prevalence rises as people get older. As a result, chronic diseases are expected to rise even more throughout the forecast period as the global geriatric population grows. This is expected to provide considerable growth opportunities for the digital therapeutics industry.

Global Digital Therapeutics Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Digital Therapeutics Market Segmentation

Market Breakup by Application

  • Preventive
  • Prediabetes
  • Obesity
  • Others
  • Treatment
  • Diabetes
  • Respiratory Care
  • Mental Health
  • Cardiovascular
  • Others

Market Breakup by Component

  • Software
  • Device

Market Breakup by End-user

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Market Breakup by Sales Channel

  • B2B
  • B2C

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Digital Therapeutics Market Regional Analysis

The United States, with a robust healthcare infrastructure that can integrate the digital advancements, is expected to dominate the digital therapeutics market size in the forecast period. The existence of impactful academic as well as research institutions drives the market growth in the region. The increasing adoption of telehealth services is another major aspect.

In March 2023, NeuroRPM  received the FDA clearance for using artificial intelligence enabled remote monitoring app for Parkinson’s disease. It monitors the disease indications such as bradykinesia, tremor, and dyskinesia continuously using proprietary algorithms. This indicates the ongoing trend of healthcare practitioners and companies adopting digital services to improve the treatment alternatives for patients. Similar have been employed for migraine, PTSD, psychiatric conditions, and chronic lung diseases like CAD as well.

Global Digital Therapeutics Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Digital Therapeutics Market: Competitor Landscape

In October 2023, Sidekick Health  acquired aidhere, a Germany based pioneer of prescription digital therapeutics. This acquisition also loops in zanadio, which is one of the most successful PDTs with over 50,000 prescriptions and is recognised within Germany’s self-regulated DiGA. It strengthens Sidekick Health’s portfolio as a trusted partner for pharmaceutical giants and global health insurers.

The market has been flourished with relevant developments, wherein several companies have been undergoing significant transformations to expand their product portfolio. The key features of the digital therapeutics market report include grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Omada Health, Inc.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Livongo Health, Inc. (Teladoc Health, Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Mango Health
  • Canary Health
  • Noom, Inc.
  • Pear Therapeutics, Inc.
  • Akill Interactive Labs, Inc.
  • JOGO Health
  • GAIA AG
  • CureApp, Inc.
  • Brain+ A/S

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Applications
  • Component
  • End User
  • Sales Channel
  • Region
Breakup by Applications
  • Preventive
  • Treatment
Breakup by Component
  • Software
  • Device
Breakup by End User
  • Patients
  • Providers
  • Payers
  • Employers
  • Others
Breakup by Sales Channel
  • B2B
  • B2C
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Omada Health, Inc.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Livongo Health, Inc. (Teladoc Health, Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Mango Health
  • Canary Health
  • Noom, Inc.
  • Pear Therapeutics, Inc.
  • Akill Interactive Labs, Inc.
  • JOGO Health
  • GAIA AG
  • CureApp, Inc.
  • Brain+ A/S
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

Digital Therapeutics Market Report Snapshots

Digital Therapeutics Market Size

Digital Therapeutics Regional Analysis

Digital Therapeutics Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 4.5 billion in 2024, driven by the prevalence of telehealth services across the globe.

The market is anticipated to grow at a CAGR of 31.6% during the forecast period of 2025-2034, likely to reach a market value of USD 53.2 billion by 2034.

The market demand is driven by the increasing prevalence of chronic diseases, growing geriatric population, and rising convergence of digital health and related services in the healthcare ecosystem.

The major market trend revolves around increasing mergers and collaborations between influential healthcare companies, aimed at expanding their product lines and offer digital health services to the patients. In September 2023, Bayer AG entered a collaboration with Mahana Therapeutics to commercialize irritable bowel syndrome (IBS) related digital therapies.

Software and devices are common components available in the market.

Common application areas include preventive care and treatment. Preventive is further segmented into prediabetes, obesity, and others. Treatment divides into diabetes, respiratory care, mental health, cardiovascular and others.

Based on sales channels, the market is divided into B2B and B2C.

Major end users include patients, providers, payers, employers, and others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Omada Health, Inc, Welldoc, Inc., 2Morrow, Inc., Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, Mango Health, Canary Health, Noom, Inc., Pear Therapeutics, Inc., Akill Interactive Labs, Inc., JOGO Health, GAIA AG, CureApp, Inc. and Brain+ A/S.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Selected Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Selected Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124